Category Archives: The Charlton Centre

Last Thursday, the first dose in Canada of a new biologic treatment for psoriasis was injected at Charlton Health.  Guselkumab is marketed under the name of Tremfya and is approved by Health Canada for moderate to severe plaque  psoriasis.  It … Continue reading →

In April of 2017 a new form of hormone therapy was approved by Health Canada for women with an intact uterus.  It has already been in the United States for over a year. When giving systemic doses of estrogen for … Continue reading →

Normal changes in memory occur with aging, but it is important to recognize changes that require further assessment. Alzheimer’s Disease changes may include: poor judgement and decision making, new problems with words in speaking or writing, changes in mood and … Continue reading →

HDL (high density lipoproteins)  have always been known as the good cholesterol as they can pull “bad cholesterol” away from the blood vessel wall. At the 2017 North American Menopause Society Meeting held last month in Philadelphia, research was presented that … Continue reading →

Dr. Neil Binkley is part of the Osteoporosis Clinical Research Program at the University of Wisconsin. He was very passionate about preventing fractures as the consequences of breaking a weakened bone are significant and greatly affect a person’s ability to … Continue reading →

This week, we’re pleased to be bringing you information on an upcoming FREE forum that our pharmacist, Carolyn Whiskin, will be speaking at. The Ontario Pain Foundation regularly hosts these sorts of forums on a wide range of topics surrounding … Continue reading →

Photo from: http://diabetestimes.co.uk/special-baby-formula-does-not-affect-type-1-diabetes/ Healthy mom equals healthy baby. This was the clear message from an educational forum on the treament of autoimmune diseases during pregnancy. Many of the medications used for autoimmune conditions such as inflammatory arthritis, inflammatory bowel disease … Continue reading →

The GLA:D program is an education and exercise program developed by researchers in Denmark for individuals with hip or knee osteoarthritis symptoms. Research from the GLA:D program in Denmark has shown a reduction in progression of symptoms by 27%. Other outcomes … Continue reading →

Uveitis occurs when then middle layer of the lining of the eye called the uvea becomes inflammed.  This condition can happen without any known underlying cause but can also occur in people with rhuematic conditions such as, ankylosing spondylitis, juvenille rheumatoid … Continue reading →

This question is commonly asked by patients. No one likes to take a medication unneccessarily and once a person feels well, it a not uncommon to want to see if they can stop their medication.  In the case of an … Continue reading →